Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review

July 2021 | 52 pages | ID: D2457DB0B1EEN
GlobalData

Abstracts

Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Daewoong Pharmaceutical Co Ltd (Daewoong Pharmaceutical), a subsidiary of Daewoong Co Ltd, is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, healthcare products and APIs. The company produces products in the forms of tablets, capsules, ointments, injections, liquids and sprays. It offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory remedies, among others. It also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. The company operates across Asia including Indonesia, China, Vietnam, Thailand and India; and the US. Daewoong Pharmaceutical is headquartered in Seoul, South Korea.

Daewoong Pharmaceutical Co Ltd Key Recent Developments

Mar 31,2021: Daewoong Pharmaceutical signs an MOU with the Indonesian government for clinical trials for COVID-19 treatment
Nov 04,2020: Daewoong Pharmaceutical's 3rd quarter results announcement, sales of 248.9 billion won, operating profit of 7 billion won
Nov 02,2020: Daewoong Pharmaceutical participated in the Korean American Pharmaceutical Association (KASBP) Fall symposium
Sep 22,2020: Daewoong Pharmaceutical welcomes ITC decision to review judge’s initial determination
Apr 08,2020: Leading Korean pharmaceutical manufacturer transforms drug processing with Quantum 600 pump

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Daewoong Pharmaceutical Co Ltd - Key Facts
Daewoong Pharmaceutical Co Ltd - Key Employees
Daewoong Pharmaceutical Co Ltd - Major Products and Services
Daewoong Pharmaceutical Co Ltd - History
Daewoong Pharmaceutical Co Ltd - Company Statement
Daewoong Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Daewoong Pharmaceutical Co Ltd - Business Description
Business Segment: Others/etc.
Performance
Business Segment: Pharmaceutical Manufacturing and Sales
Performance
Business Segment: Service Provision/Provided
Performance
Daewoong Pharmaceutical Co Ltd - Corporate Strategy
Daewoong Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Daewoong Pharmaceutical Co Ltd - Strengths
Daewoong Pharmaceutical Co Ltd - Weaknesses
Daewoong Pharmaceutical Co Ltd - Opportunities
Daewoong Pharmaceutical Co Ltd - Threats
Daewoong Pharmaceutical Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Daewoong Pharmaceutical Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 31, 2021: Daewoong Pharmaceutical signs an MOU with the Indonesian government for clinical trials for COVID-19 treatment
Nov 04, 2020: Daewoong Pharmaceutical's 3rd quarter results announcement, sales of 248.9 billion won, operating profit of 7 billion won
Nov 02, 2020: Daewoong Pharmaceutical participated in the Korean American Pharmaceutical Association (KASBP) Fall symposium
Sep 22, 2020: Daewoong Pharmaceutical welcomes ITC decision to review judge’s initial determination
Apr 08, 2020: Leading Korean pharmaceutical manufacturer transforms drug processing with Quantum 600 pump
Feb 12, 2020: Daewoong Pharmaceutical accelerates global new drug development via MOU with ADM Korea
Jan 17, 2020: Daewoong Pharmaceutical presents roadmap for development of rare incurable disease drugs through open collaboration
Jan 06, 2020: Daewoong Pharmaceutical, world’s first halal certification for biopharmaceutical product derived from animal cells through Indonesian joint venture, Daewoong Infion.
Jan 02, 2020: Daewoong Pharmaceutical, “Focusing on Its Company-wide Capabilities for Global Vision 2025”

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Daewoong Pharmaceutical Co Ltd, Key Facts
Daewoong Pharmaceutical Co Ltd, Key Employees
Daewoong Pharmaceutical Co Ltd, Major Products and Services
Daewoong Pharmaceutical Co Ltd, History
Daewoong Pharmaceutical Co Ltd, Other Locations
Daewoong Pharmaceutical Co Ltd, Subsidiaries
Daewoong Pharmaceutical Co Ltd, Joint Venture
Daewoong Pharmaceutical Co Ltd, Key Competitors
Daewoong Pharmaceutical Co Ltd, Ratios based on current share price
Daewoong Pharmaceutical Co Ltd, Annual Ratios
Daewoong Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Daewoong Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Daewoong Pharmaceutical Co Ltd, Interim Ratios
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Daewoong Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Daewoong Pharmaceutical Co Ltd, Performance Chart (2016 - 2020)
Daewoong Pharmaceutical Co Ltd, Ratio Charts
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Daewoong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021